Support for Patients and Communities Reauthorization Act

Hozzl · 2024-02-06T18:49:25Z

Explore the details of House Bill 4531 Support for Patients and Communities Reauthorization Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/6/2024, 6:49 PM

Summary of Bill HR 4531

The Support for Patients and Communities Reauthorization Act, also known as Bill 118 hr 4531, is a piece of legislation currently being considered by the US Congress. This bill aims to address the ongoing opioid crisis in the United States by providing support and resources for patients and communities affected by opioid addiction.

The main provisions of the bill include increasing funding for opioid treatment and prevention programs, expanding access to medication-assisted treatment for individuals struggling with opioid addiction, and improving coordination between federal, state, and local agencies in addressing the crisis. Additionally, the bill seeks to enhance data collection and reporting on opioid-related deaths and overdoses to better understand the scope of the problem and inform future policy decisions.

Overall, the Support for Patients and Communities Reauthorization Act is a comprehensive effort to combat the opioid crisis and provide much-needed support for individuals and communities impacted by addiction. It represents a bipartisan effort to address a pressing public health issue and has the potential to make a significant impact in the fight against opioid abuse in the United States.

Congressional Summary of HR 4531

Support for Patients and Communities Reauthorization Act

This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse.

This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs.

Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act.

Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4531

Bill HR 4531 is currently in the status of Introduced to Senate since December 13, 2023. Bill HR 4531 was introduced during Congress 118 and was introduced to the House on July 11, 2023. Bill HR 4531's most recent activity was Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of December 13, 2023